Larvol Delta - Safety-and-superior-immunogenicity-of-heterologous-boosting-with-an-RBDbased-SARSCoV2-mRNA-vaccine-in-Chinese-adults

ARCoV - Walvax, Academy of Military Medical Sciences, Suzhou Abogen Biosci

http://www.ncbi.nlm.nih.gov/pubmed/35701541

Jun 18, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next